Top

Endocrine

Published in:

Open Access 18-05-2022 | Congenital Adrenal Hyperplasia | Review

Adrenal crises in adolescents and young adults

Authors: R. Louise Rushworth, Georgina L. Chrisp, Suzannah Bownes, David J. Torpy, Henrik Falhammar

Published in: Endocrine | Issue 1/2022

Abstract

Purpose

Review the literature concerning adrenal insufficiency (AI) and adrenal crisis (AC) in adolescents and young adults.

Methods

Searches of PubMed identifying relevant reports up to March 2022.

Results

AI is rare disorder that requires lifelong glucocorticoid replacement therapy and is associated with substantial morbidity and occasional mortality among adolescents and young adults. Aetiologies in this age group are more commonly congenital, with acquired causes, resulting from tumours in the hypothalamic-pituitary area and autoimmune adrenalitis among others, increasing with age. All patients with AI are at risk of AC, which have an estimated incidence of 6 to 8 ACs/100 patient years. Prevention of ACs includes use of educational interventions to achieve competency in dose escalation and parenteral glucocorticoid administration during times of physiological stress, such as an intercurrent infection. While the incidence of AI/AC in young children and adults has been documented, there are few studies focussed on the AC occurrence in adolescents and young adults with AI. This is despite the range of developmental, psychosocial, and structural changes that can interfere with chronic disease management during this important period of growth and development.

Conclusion

In this review, we examine the current state of knowledge of AC epidemiology in emerging adults; examine the causes of ACs in this age group; and suggest areas for further investigation that are aimed at reducing the incidence and health impact of ACs in these patients.

S.R. Bornstein, B. Allolio, W. Arlt, A. Barthel, A. Don-Wauchope, G.D. Hammer, E.S. Husebye, D.P. Merke, M.H. Murad, C.A. Stratakis, D.J. Torpy, Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 101(2), 364–389 (2016). https://doi.org/10.1210/jc.2015-1710CrossRefPubMed

R.L. Rushworth, D.J. Torpy, C.A. Stratakis, H. Falhammar, Adrenal crises in children: perspectives and research directions. Horm. Res. Paediatr. 89(5), 341–351 (2018). https://doi.org/10.1159/000481660CrossRefPubMed

J. Park, M. Didi, J. Blair, The diagnosis and treatment of adrenal insufficiency during childhood and adolescence. Arch. Dis. Child 101(9), 860–865 (2016). https://doi.org/10.1136/archdischild-2015-308799CrossRefPubMed

P.H. Tallis, R.L. Rushworth, D.J. Torpy, H. Falhammar, Adrenal insufficiency due to bilateral adrenal metastases—a systematic review and meta-analysis. Heliyon 5(5), e01783 (2019). https://doi.org/10.1016/j.heliyon.2019.e01783CrossRefPubMedPubMedCentral

M. Ventura, J. Serra-Caetano, R. Cardoso, I. Dinis, M. Melo, F. Carrilho, A. Mirante, The spectrum of pediatric adrenal insufficiency: insights from 34 years of experience. J. Pediatr. Endocrinol. Metab. 32(7), 721–726 (2019). https://doi.org/10.1515/jpem-2019-0030CrossRefPubMed

L.H. Broersen, A.M. Pereira, J.O. Jorgensen, O.M. Dekkers, Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 100(6), 2171–2180 (2015). https://doi.org/10.1210/jc.2015-1218CrossRefPubMed

A.G. Hayes, R.L. Rushworth, D.J. Torpy, Risk assessment, diagnosis, and treatment of cancer treatment-related adrenal insufficiency. Expert Rev. Endocrinol. Metab. 17(1), 21–33 (2022). https://doi.org/10.1080/17446651.2022.2023009CrossRefPubMed

R.L. Rushworth, D.J. Torpy, H. Falhammar, Adrenal crisis. N. Engl. J. Med. 381(9), 852–861 (2019). https://doi.org/10.1056/NEJMra1807486CrossRefPubMed

A.B. Saevik, A.K. Akerman, K. Gronning, I. Nermoen, S.F. Valland, T.E. Finnes, M. Isaksson, P. Dahlqvist, R. Bergthorsdottir, O. Ekwall, J. Skov, B.G. Nedrebo, A.L. Hulting, J. Wahlberg, J. Svartberg, C. Hoybye, I.H. Bleskestad, A.P. Jorgensen, O. Kampe, M. Oksnes, S. Bensing, E.S. Husebye, Clues for early detection of autoimmune Addison’s disease—myths and realities. J. Intern. Med. 283(2), 190–199 (2018). https://doi.org/10.1111/joim.12699CrossRefPubMed

10.

H. Nowotny, S.F. Ahmed, S. Bensing, J.G. Beun, M. Brosamle, I. Chifu, H. Claahsen van der Grinten, M. Clemente, H. Falhammar, S. Hahner, E. Husebye, J. Kristensen, P. Loli, S. Lajic, N. Reisch, E.R.N. Endo, Therapy options for adrenal insufficiency and recommendations for the management of adrenal crisis. Endocrine 71(3), 586–594 (2021). https://doi.org/10.1007/s12020-021-02649-6CrossRefPubMedPubMedCentral

11.

S. Bird, Failure to diagnose: Addison disease. Aust. Fam. Physician 36(10), 859–861 (2007)PubMed

12.

K. Suknuntha, Q. Yu, P.S. Weisman, R.F. Corliss, Fatal adrenal crisis due to Addison’s disease arising in the context of autoimmune polyglandular syndrome type 1. Forensic Sci. Med Pathol. 16(1), 166–170 (2020). https://doi.org/10.1007/s12024-019-00204-4CrossRefPubMed

13.

S. Hahner, C. Spinnler, M. Fassnacht, S. Burger-Stritt, K. Lang, D. Milovanovic, F. Beuschlein, H.S. Willenberg, M. Quinkler, B. Allolio, High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. J. Clin. Endocrinol. Metab. 100(2), 407–416 (2015). https://doi.org/10.1210/jc.2014-3191CrossRefPubMed

14.

R.L. Rushworth, D.J. Torpy, H. Falhammar, Adrenal crises in older patients. Lancet Diabetes Endocrinol. 8(7), 628–639 (2020). https://doi.org/10.1016/S2213-8587(20)30122-4CrossRefPubMed

15.

D.P. Merke, D.P. Poppas, Management of adolescents with congenital adrenal hyperplasia. Lancet Diabetes Endocrinol. 1(4), 341–352 (2013). https://doi.org/10.1016/S2213-8587(13)70138-4CrossRefPubMedPubMedCentral

16.

B. Graulich, K. Irizarry, C. Orlowski, C.A. Wittlieb-Weber, D.R. Weber, Severe multisystem organ dysfunction in an adolescent with simultaneous presentation of Addison’s and Graves’ disease. J. Pediatr. Endocrinol. Metab. 34(3), 411–415 (2021). https://doi.org/10.1515/jpem-2020-0438CrossRefPubMed

17.

M.B. Roldan-Martin, A. Rodriguez-Ogando, A.C. Sanchez-Galindo, A. Parente-Hernandez, V. Luengo-Herrero, C. Sanchez-Sanchez, Rare presentation of shock and acute mesenteric ischaemia secondary to acute adrenal insufficiency in an 11-year-old male. J. Paediatr. Child Health 49(6), 498–500 (2013). https://doi.org/10.1111/j.1440-1754.2012.02556.xCrossRefPubMed

18.

B. Allolio, K. Lang, S. Hahner, Addisonian crisis in a young man with atypical anorexia nervosa. Nat. Rev. Endocrinol. 7(2), 115–121 (2011). https://doi.org/10.1038/nrendo.2010.211CrossRefPubMed

19.

S. Pintaldi, A. Lora, K. Vecchiato, A. Taddio, E. Barbi, SIADH versus adrenal insufficiency: a life-threatening misdiagnosis. Ital. J. Pediatr. 45(1), 23 (2019). https://doi.org/10.1186/s13052-019-0614-1CrossRefPubMedPubMedCentral

20.

P.J. Simm, C.M. McDonnell, M.R. Zacharin, Primary adrenal insufficiency in childhood and adolescence: advances in diagnosis and management. J. Paediatr. Child Health 40(11), 596–599 (2004). https://doi.org/10.1111/j.1440-1754.2004.00482.xCrossRefPubMed

21.

M.Y. Kwok, M.C. Scanlon, A.H. Slyper, Atypical presentation of shock from acute adrenal insufficiency in an adolescent male. Pediatr. Emerg. Care 21(6), 380–383 (2005). https://doi.org/10.1097/01.pec.0000166730.63223.b2CrossRefPubMed

22.

R.L. Rushworth, G.L. Chrisp, B. Dean, H. Falhammar, D.J. Torpy, Hospitalisation in children with adrenal insufficiency and hypopituitarism: is there a differential burden between boys and girls and between age groups? Horm. Res. Paediatr. 88(5), 339–346 (2017). https://doi.org/10.1159/000479370CrossRefPubMed

23.

R.L. Rushworth, D.J. Torpy, A descriptive study of adrenal crises in adults with adrenal insufficiency: increased risk with age and in those with bacterial infections. BMC Endocr. Disord. 14, 79 (2014). https://doi.org/10.1186/1472-6823-14-79CrossRefPubMedPubMedCentral

24.

G.L., Chrisp, A.M., Maguire, M. Quartararo, H. Falhammar, B.R. King, C.F. Munns, D.J. Torpy, S. Hameed, R.L. Rushworth, Variations in the management of acute illness in children with congenital adrenal hyperplasia: an audit of three paediatric hospitals. Clin. Endocrinol. (2018). https://doi.org/10.1111/cen.13826

25.

R.L. Rushworth, H. Falhammar, C.F. Munns, A.M. Maguire, D.J. Torpy, Hospital admission patterns in children with CAH: admission rates and adrenal crises decline with age. Int J. Endocrinol. 2016, 5748264 (2016). https://doi.org/10.1155/2016/5748264CrossRefPubMedPubMedCentral

26.

K. Omori, K. Nomura, S. Shimizu, N. Omori, K. Takano, Risk factors for adrenal crisis in patients with adrenal insufficiency. Endocr. J. 50(6), 745–752 (2003). https://doi.org/10.1507/endocrj.50.745CrossRefPubMed

27.

N. Reisch, M. Willige, D. Kohn, H.P. Schwarz, B. Allolio, M. Reincke, M. Quinkler, S. Hahner, F. Beuschlein, Frequency and causes of adrenal crises over lifetime in patients with 21-hydroxylase deficiency. Eur. J. Endocrinol. 167(1), 35–42 (2012). https://doi.org/10.1530/EJE-12-0161CrossRefPubMed

28.

T. Goubar, D.J. Torpy, S. McGrath, R.L. Rushworth, Prehospital management of acute addison disease: audit of patients attending a referral hospital in a regional area. J. Endocr. Soc. 3(12), 2194–2203 (2019). https://doi.org/10.1210/js.2019-00263CrossRefPubMedPubMedCentral

29.

R.L. Rushworth, T. Goubar, C. Ostman, S. McGrath, D.J. Torpy, Interaction between hypotension and age on adrenal crisis diagnosis. Endocrinol. Diabetes Metab. 4(2), e00205 (2021). https://doi.org/10.1002/edm2.205CrossRefPubMed

30.

O. Eyal, Y. Levin, A. Oren, A. Zung, M. Rachmiel, Z. Landau, A. Schachter-Davidov, A. Segev-Becker, N. Weintrob, Adrenal crises in children with adrenal insufficiency: epidemiology and risk factors. Eur. J. Pediatr. 178(5), 731–738 (2019). https://doi.org/10.1007/s00431-019-03348-1CrossRefPubMed

31.

S. Hahner, M. Loeffler, B. Bleicken, C. Drechsler, D. Milovanovic, M. Fassnacht, M. Ventz, M. Quinkler, B. Allolio, Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies. Eur. J. Endocrinol. 162(3), 597–602 (2010). https://doi.org/10.1530/EJE-09-0884CrossRefPubMed

32.

R.L. Rushworth, N. Gouvoussis, T. Goubar, A. Maguire, C.F. Munns, K.A. Neville, D.J. Torpy, Acute illness in children with secondary adrenal insufficiency. Clin. Endocrinol. 94(6), 913–919 (2021). https://doi.org/10.1111/cen.14427CrossRef

33.

M.M. Erichsen, K. Lovas, K.J. Fougner, J. Svartberg, E.R. Hauge, J. Bollerslev, J.P. Berg, B. Mella, E.S. Husebye, Normal overall mortality rate in Addison’s disease, but young patients are at risk of premature death. Eur. J. Endocrinol. 160(2), 233–237 (2009). https://doi.org/10.1530/EJE-08-0550CrossRefPubMed

34.

H. Falhammar, L. Frisen, C. Norrby, A.L. Hirschberg, C. Almqvist, A. Nordenskjold, A. Nordenstrom, Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 99(12), E2715–E2721 (2014). https://doi.org/10.1210/jc.2014-2957CrossRefPubMed

35.

I. Bancos, J. Hazeldine, V. Chortis, P. Hampson, A.E. Taylor, J.M. Lord, W. Arlt, Primary adrenal insufficiency is associated with impaired natural killer cell function: a potential link to increased mortality. Eur. J. Endocrinol. 176(4), 471–480 (2017). https://doi.org/10.1530/EJE-16-0969CrossRefPubMedPubMedCentral

36.

R.L. Rushworth, D.J. Torpy, H. Falhammar, Adrenal crises: perspectives and research directions. Endocrine 55(2), 336–345 (2017). https://doi.org/10.1007/s12020-016-1204-2CrossRefPubMed

37.

G.L. Chrisp, M. Quartararo, D.J. Torpy, H. Falhammar, R.L. Rushworth, Use of medical identification jewellery in children and young adults with adrenal insufficiency in Australia. Endocrine 72(2), 539–545 (2021). https://doi.org/10.1007/s12020-020-02595-9CrossRefPubMed

38.

S. Gidlöf, H. Falhammar, A. Thilén, A. von Döbeln, M. Ritzén, A. Wedell, A. Nordenström, One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective, population-based cohort study. Lancet Diabetes Endocrinol. 1(1), 35–43 (2013). https://doi.org/10.1016/S2213-8587(13)70007-XCrossRefPubMed

39.

S. Hsieh, P.C. White, Presentation of primary adrenal insufficiency in childhood. J. Clin. Endocrinol. Metab. 96(6), E925–E928 (2011). https://doi.org/10.1210/jc.2011-0015CrossRefPubMed

40.

K. Ekbom, A. Strandqvist, S. Lajic, A.L. Hirschberg, H. Falhammar, A. Nordenstrom, Assessment of medication adherence in children and adults with congenital adrenal hyperplasia and the impact of knowledge and self-management. Clin. Endocrinol. 94(5), 753–764 (2021). https://doi.org/10.1111/cen.14398CrossRef

41.

K. Ekbom, A. Strandqvist, S. Lajic, A. Hirschberg, H. Falhammar, A. Nordenstrom, The impact of adherence and therapy regimens on quality of life in patients with congenital adrenal hyperplasia. Clin. Endocrinol. (2022). https://doi.org/10.1111/cen.14676

42.

E. Charmandari, P.C. Hindmarsh, A. Johnston, C.G. Brook, Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: alterations in cortisol pharmacokinetics at puberty. J. Clin. Endocrinol. Metab. 86(6), 2701–2708 (2001)CrossRef

43.

L. Bessiène, H. Ségolène, A. Bourdin-Pintueles, L. Dumeige, G. Vitellius, J. Perrot, Q.-Y. Xu, T.-A. Vu, L. Sachs, E. Pussard, M. Lombès, S. Viengchareun, L. Martinerie, Thyroid hormones are new key regulators of glucocorticoid metabolism. In: 21st European Congress of Endocrinology, Lyon, France 2019

44.

A. Nordenstrom, H. Falhammar, S. Lajic, Current and novel treatment strategies in children with congenital adrenal hyperplasia. Horm. Res. Paediatr. (2022). https://doi.org/10.1159/000522260

45.

W. Bonfig, S.B. Pozza, H. Schmidt, P. Pagel, D. Knorr, H.P. Schwarz, Hydrocortisone dosing during puberty in patients with classical congenital adrenal hyperplasia: an evidence-based recommendation. J. Clin. Endocrinol. Metab. 94(10), 3882–3888 (2009). https://doi.org/10.1210/jc.2009-0942CrossRefPubMed

46.

H. Gleeson, J. Davis, J. Jones, E. O’Shea, P.E. Clayton, The challenge of delivering endocrine care and successful transition to adult services in adolescents with congenital adrenal hyperplasia: experience in a single centre over 18 years. Clin. Endocrinol. 78(1), 23–28 (2013). https://doi.org/10.1111/cen.12053CrossRef

47.

M. Quinkler, R.D. Murray, P. Zhang, C. Marelli, R. Petermann, A.M. Isidori, B. Ekman, Characterization of patients with adrenal insufficiency and frequent adrenal crises. Eur. J. Endocrinol. 184(6), 761–771 (2021). https://doi.org/10.1530/EJE-20-1324CrossRefPubMedPubMedCentral

48.

G. Meyer, K. Badenhoop, R. Linder, Addison’s disease with polyglandular autoimmunity carries a more than 2.5-fold risk for adrenal crises: German Health insurance data 2010-2013. Clin. Endocrinol. 85(3), 347–353 (2016). https://doi.org/10.1111/cen.13043CrossRef

49.

B. Mortimer, V.D. Naganur, P. Satouris, J.R. Greenfield, D.J. Torpy, R.L. Rushworth, Acute illness in patients with concomitant Addison’s disease and type 1 diabetes mellitus: Increased incidence of hypoglycaemia and adrenal crises. Clin. Endocrinol. 93(2), 104–110 (2020). https://doi.org/10.1111/cen.14219CrossRef

50.

J.B. Thomas, N. Petrovsky, G.R. Ambler, Addison’s disease presenting in four adolescents with type 1 diabetes. Pediatr. Diabetes 5(4), 207–211 (2004). https://doi.org/10.1111/j.1399-543X.2004.00056.xCrossRefPubMed

51.

S.B. Sorenson, Gender disparities in injury mortality: consistent, persistent, and larger than you’d think. Am. J. Public Health 101(Suppl 1), S353–S358 (2011). https://doi.org/10.2105/AJPH.2010.300029CrossRefPubMedPubMedCentral

52.

H. Falhammar, H. Filipsson Nystrom, A. Wedell, M. Thoren, Cardiovascular risk, metabolic profile, and body composition in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Eur. J. Endocrinol. 164(2), 285–293 (2011). https://doi.org/10.1530/EJE-10-0877CrossRefPubMed

53.

D. El-Maouche, C.J. Hargreaves, N. Sinaii, A. Mallappa, P. Veeraraghavan, D.P. Merke, Longitudinal assessment of illnesses, stress dosing, and illness sequelae in patients with congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 103(6), 2336–2345 (2018). https://doi.org/10.1210/jc.2018-00208CrossRefPubMedPubMedCentral

54.

R.L. Rushworth, D.J. Torpy, Modern hydrocortisone replacement regimens in adrenal insufficiency patients and the risk of adrenal crisis. Horm. Metab. Res. 47(9), 637–642 (2015). https://doi.org/10.1055/s-0035-1548869CrossRefPubMed

55.

R.L. Rushworth, D.J. Torpy, Adrenal insufficiency in Australia: is it possible that the use of lower dose, short-acting glucocorticoids has increased the risk of adrenal crises? Horm. Metab. Res. 47(6), 427–432 (2015). https://doi.org/10.1055/s-0034-1395680CrossRefPubMed

56.

R.L. Rushworth, G.L. Chrisp, D.J. Torpy, Glucocorticoid-induced adrenal insufficiency: a study of the incidence in hospital patients and a review of peri-operative management. Endocr. Pract. 24(5), 437–445 (2018). https://doi.org/10.4158/EP-2017-0117CrossRefPubMed

57.

T. Li, J.L. Cunningham, W.P. Gilliam, L. Loukianova, D.M. Donegan, I. Bancos, Prevalence of opioid-induced adrenal insufficiency in patients taking chronic opioids. J. Clin. Endocrinol. Metab. 105(10) (2020). https://doi.org/10.1210/clinem/dgaa499

58.

S. Chiloiro, A. Bianchi, A. Giampietro, D. Milardi, L. De Marinis, A. Pontecorvi, The changing clinical spectrum of endocrine adverse events in cancer immunotherapy. Trends Endocrinol. Metab. 33(2), 87–104 (2022). https://doi.org/10.1016/j.tem.2021.10.009CrossRefPubMed

59.

L.C. Smans, E.S. Van der Valk, A.R. Hermus, P.M. Zelissen, Incidence of adrenal crisis in patients with adrenal insufficiency. Clin. Endocrinol. 84(1), 17–22 (2016). https://doi.org/10.1111/cen.12865CrossRef

60.

C. Schofl, B. Mayr, N. Maison, F. Beuschlein, G. Meyer, K. Badenhoop, T. Kienitz, M. Quinkler, Daily adjustment of glucocorticoids by patients with adrenal insufficiency. Clin. Endocrinol. 91(2), 256–262 (2019). https://doi.org/10.1111/cen.14004CrossRef

61.

A.S.Y. Nip, M. Lodish, Trend of diabetes-related hospital admissions during the transition period from adolescence to adulthood in the state of California. Diabetes Care 44(12), 2723–2728 (2021). https://doi.org/10.2337/dc21-0555CrossRefPubMed

62.

A. Colver, H. McConachie, A. Le Couteur, G. Dovey-Pearce, K.D. Mann, J.E. McDonagh, M.S. Pearce, L. Vale, H. Merrick, J.R. Parr; Transition Collaborative, G., A longitudinal, observational study of the features of transitional healthcare associated with better outcomes for young people with long-term conditions. BMC Med. 16(1), 111 (2018). https://doi.org/10.1186/s12916-018-1102-yCrossRefPubMedPubMedCentral

63.

A.O. Hersh, S. Pang, M.L. Curran, D.S. Milojevic, E. von Scheven, The challenges of transferring chronic illness patients to adult care: reflections from pediatric and adult rheumatology at a US academic center. Pediatr. Rheumatol. Online J. 7, 13 (2009). https://doi.org/10.1186/1546-0096-7-13CrossRefPubMedPubMedCentral

64.

L. van Alewijk, K. Davidse, K. Pellikaan, J. van Eck, A.C.S. Hokken-Koelega, T.C.J. Sas, S. Hannema, A.J. van der Lely, L.C.G. de Graaff, Transition readiness among adolescents with rare endocrine conditions. Endocr. Connect 10(4), 432–446 (2021). https://doi.org/10.1530/EC-20-0304CrossRefPubMedPubMedCentral

65.

J. Downing, H.K. Gleeson, P.E. Clayton, J.R. Davis, J.K. Wales, P. Callery, Transition in endocrinology: the challenge of maintaining continuity. Clin. Endocrinol. 78(1), 29–35 (2013). https://doi.org/10.1111/j.1365-2265.2012.04473.xCrossRef

66.

R. Crowley, I. Wolfe, K. Lock, M. McKee, Improving the transition between paediatric and adult healthcare: a systematic review. Arch. Dis. Child. 96(6), 548–553 (2011). https://doi.org/10.1136/adc.2010.202473CrossRefPubMed

67.

A.P. Vidmar, J.F. Weber, R. Monzavi, C.M. Koppin, M.S. Kim, Improved medical-alert ID ownership and utilization in youth with congenital adrenal hyperplasia following a parent educational intervention. J. Pediatr. Endocrinol. Metab. 31(2), 213–219 (2018). https://doi.org/10.1515/jpem-2017-0435CrossRefPubMedPubMedCentral

68.

H.L. Claahsen-van der Grinten, P.W. Speiser, S.F. Ahmed, W. Arlt, R.J. Auchus, H. Falhammar, C.E. Fluck, L. Guasti, A. Huebner, B.B.M. Kortmann, N. Krone, D.P. Merke, W.L. Miller, A. Nordenstrom, N. Reisch, D.E. Sandberg, N. Stikkelbroeck, P. Touraine, A. Utari, S.A. Wudy, P.C. White, Congenital adrenal hyperplasia-current insights in pathophysiology, diagnostics, and management. Endocr. Rev. 43(1), 91–159 (2022). https://doi.org/10.1210/endrev/bnab016CrossRefPubMed

69.

S. Hahner, R.J. Ross, W. Arlt, I. Bancos, S. Burger-Stritt, D.J. Torpy, E.S. Husebye, M. Quinkler, Adrenal insufficiency. Nat. Rev. Dis. Prim. 7(1), 19 (2021). https://doi.org/10.1038/s41572-021-00252-7CrossRefPubMed

70.

K. Mariniello, L. Guasti, Towards novel treatments for adrenal diseases: cell- and gene therapy-based approaches. Mol. Cell. Endocrinol. 524, 111160 (2021). https://doi.org/10.1016/j.mce.2021.111160CrossRefPubMed

Title: Adrenal crises in adolescents and young adults
Authors: R. Louise Rushworth
Georgina L. Chrisp
Suzannah Bownes
David J. Torpy
Henrik Falhammar
Publication date: 18-05-2022
Publisher: Springer US
Keywords: Congenital Adrenal Hyperplasia
Congenital Adrenal Hyperplasia
Glucocorticoid
Published in: Endocrine / Issue 1/2022
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-022-03070-3

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2022

Performance of the aldosterone-to-renin ratio as a screening test for primary aldosteronism in primary care

Differentiated thyroid carcinoma in the elderly: influence of age on disease-free and overall survival

A combined index of waist circumference and muscle quality is associated with cardiovascular disease risk factor accumulation in Japanese obese patients: a cross-sectional study

Free fatty acids are associated with muscle dysfunction in Chinese adults with type 2 diabetes

Distribution of E- and N-cadherin in subgroups of non-functioning pituitary neuroendocrine tumours

Levothyroxine treatment and gastric juice pH in humans: the proof of concept

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials